Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Cancer

NSAIDs may help protect against skin cancer

Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) may play a therapeutic role in reducing the risk of squamous cell carcinoma, a systematic review finds.

nsaids skin biopsy solar elastosis actinic keratosis 14

Source: Shutterstock.com

Data support an inverse link between use of oral non-steroidal anti-inflammatory drugs and the incidence of squamous cell carcinoma (SCC), particularly in people with a high prevalence of actinic keratoses (pictured)

The use of non-steroidal anti-inflammatory drugs (NSAIDs), a class of medicines used to treat pain and inflammation, is associated with a reduced risk of developing cutaneous squamous cell carcinoma (SCC), a type of skin cancer, research suggests.

The systematic review and meta-analysis of published studies found that the risk reduction was greatest with non-aspirin NSAIDs and in the subgroup of people at high risk for developing SCC, and appears in the Journal of Investigative Dermatology[1].

For exposure to non-aspirin NSAIDs, the adjusted odds ratio (OR) for SCC was 0.85 (95% CI 0.78–0.94), indicating a significant risk reduction. For exposure to aspirin or non-aspirin NSAIDs, the pooled estimate was also significant, at 0.83 (95% CI 0.71–0.96).

The overall pooled estimate for the ever-use of aspirin and risk of SCC was 0.88 (95% CI 0.75–1.03), which had borderline statistical significance. The estimate did not vary according to study design or method of exposure assessment and there was no evidence of publication bias. The odds ratio (OR) tended to be lower in studies conducted mostly among people at high risk of skin cancer, however.

The researchers identified nine studies that reported risks of SCC in relation to use of the drugs; five were case–control, three were cohort and one was an interventional study. Six were considered to be of high quality while the rest were low-to-moderate quality.

Adèle Green from QIMR Berghofer Medical Research Institute, Australia, and co-authors, says: “Synthesis of existing published data supports a significant inverse association between oral NSAIDS use and incidence of cutaneous SCC, particularly among people with a high prevalence of actinic keratoses or a history of keratinocyte cancers.”

Further research is required, say the authors, to account for participants’ sun exposure along with accurate assessment of NSAIDS dosages and information about the reasons for NSAIDs use.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067482

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Introduction to Clinical Pharmaceutics (An)

    Introduction to Clinical Pharmaceutics (An)

    This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.

    £27.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • nsaids skin biopsy solar elastosis actinic keratosis 14

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.